<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: The <z:chebi fb="199" ids="26708">sodium</z:chebi>/<z:chebi fb="1" ids="16382">iodide</z:chebi> symporter (<z:chebi fb="15" ids="53204">NIS</z:chebi>) is a plasma membrane <z:chebi fb="2" ids="17089">glycoprotein</z:chebi> that mediates <z:chebi fb="1" ids="16382">iodide</z:chebi> (I-) transport in the thyroid, lactating breast, salivary glands, and stomach </plain></SENT>
<SENT sid="1" pm="."><plain>Whereas <z:chebi fb="15" ids="53204">NIS</z:chebi> expression and regulation have been extensively investigated in healthy and neoplastic thyroid and breast tissues, little is known about <z:chebi fb="15" ids="53204">NIS</z:chebi> expression and function along the healthy and diseased gastrointestinal tract </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Thus, we investigated <z:chebi fb="15" ids="53204">NIS</z:chebi> expression by immunohistochemical analysis in 155 gastrointestinal tissue samples and by immunoblot analysis in 17 gastric <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> from 83 patients </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: Regarding the healthy Gl tract, we observed <z:chebi fb="15" ids="53204">NIS</z:chebi> expression exclusively in the basolateral region of the gastric mucin-producing epithelial cells </plain></SENT>
<SENT sid="4" pm="."><plain>In <z:hpo ids='HP_0005263'>gastritis</z:hpo>, positive <z:chebi fb="15" ids="53204">NIS</z:chebi> staining was observed in these cells both in the presence and absence of Helicobacter pylori </plain></SENT>
<SENT sid="5" pm="."><plain>Significantly, <z:chebi fb="15" ids="53204">NIS</z:chebi> expression was absent in <z:hpo ids='HP_0012126'>gastric cancer</z:hpo>, independently of its histological type </plain></SENT>
<SENT sid="6" pm="."><plain>Only focal faint <z:chebi fb="15" ids="53204">NIS</z:chebi> expression was detected in the direct vicinity of <z:e sem="disease" ids="C0038356" disease_type="Neoplastic Process" abbrv="">gastric tumors</z:e>, i.e., in the histologically intact mucosa, the expression becoming gradually stronger and linear farther away from the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>Barrett mucosa with junctional and fundic-type columnar <z:mpath ids='MPATH_160'>metaplasia</z:mpath> displayed positive <z:chebi fb="15" ids="53204">NIS</z:chebi> staining, whereas Barrett mucosa with <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath> was negative </plain></SENT>
<SENT sid="8" pm="."><plain><z:chebi fb="15" ids="53204">NIS</z:chebi> staining was also absent in intestinalized <z:mp ids='MP_0003299'>gastric polyps</z:mp> </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSION: That <z:chebi fb="15" ids="53204">NIS</z:chebi> expression is markedly decreased or absent in case of intestinalization or <z:e sem="disease" ids="C1608408" disease_type="Neoplastic Process" abbrv="">malignant transformation</z:e> of the gastric mucosa suggests that <z:chebi fb="15" ids="53204">NIS</z:chebi> may prove to be a significant <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> marker in the diagnosis and prognosis of <z:e sem="disease" ids="C0024623" disease_type="Neoplastic Process" abbrv="">gastric malignancies</z:e> and also <z:e sem="disease" ids="C0940937" disease_type="Neoplastic Process" abbrv="">precancerous lesions</z:e> such as Barrett mucosa, thus extending the medical significance of <z:chebi fb="15" ids="53204">NIS</z:chebi> beyond <z:hpo ids='HP_0000820'>thyroid disease</z:hpo> </plain></SENT>
</text></document>